421 results on '"Chabner BA"'
Search Results
2. Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers.
3. In memoriam. Homage to Judah Folkman.
4. Salvage therapy for diffuse large-cell lymphoma [editorial]
5. Schwartz Center Rounds. Laughter: the best medicine?
6. Schwartz Center rounds. Learning to cope: how far is too close?
7. Beyond fast track for drug approvals.
8. Histologic progression in non-Hodgkin's lymphoma
9. Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy
10. Evidence for early recruitment of granulocyte precursors during high- dose methotrexate infusions in mice
11. Deoxycytidine kinase: properties of the enzyme from human leukemic granulocytes
12. Academia-pharma intersect: providing a broader perspective on drug development synergies between academia and industry.
13. One in five cancer clinical trials is published: a terrible symptom -- what's the diagnosis?
14. Trends in the risks and benefits to patients with cancer in phase 1 clinical trials.
15. Multidisciplinary rounds. When a cancer patient commits suicide: psychosocial issues faced by patients, families, and caregivers.
16. Diffuse Large B-Cell Lymphoma Treated With R-CHOP in a Resource-Limited Setting in South Africa: A Real-World Study.
17. Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants.
18. Supporting Patients with Cancer after Dobbs v. Jackson Women's Health Organization.
19. Supreme Court and the Practice of Oncology.
20. Joseph R. Bertino, Scientist and Clinical Oncologist.
21. Stepping Down, Looking Forward.
22. Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition.
23. Remembering Joe.
24. Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
25. Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana.
26. The Occasional Reader.
27. An Homage to Two Explorers of Uncharted Cancer Waters.
28. A Medical Pearl Harbor: Pandemic Uncovers Societal Fissures and Leadership Breaches.
29. The Corruption of Science.
30. Racism and Cancer Care: A Call for Recognition and Reform.
31. Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial.
32. A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases.
33. Memorial Tribute to Eli Glatstein.
34. The Finding of N-Nitrosodimethylamine in Common Medicines.
35. Taking the Longer View of COVID-19.
36. Twenty-Five Years of The Oncologist.
37. POETIC (Program for Enhanced Training in Cancer): An Initial Experience of Supporting Capacity Building for Oncology Training in Sub-Saharan Africa.
38. Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention.
39. The Other Opioid Crisis: Just Another Drug Shortage?
40. Immuno-Oncology in China.
41. Cell-free DNA Analysis in Cancer.
42. Conflict of Interest: An Ethical Firestorm with Consequences for Cancer Research.
43. Application of Cell-free DNA Analysis to Cancer Treatment.
44. Impact of HIV Infection on the Clinical Presentation and Survival of Non-Hodgkin Lymphoma: A Prospective Observational Study From Botswana.
45. Canakinumab and Lung Cancer: Intriguing, but Is It Real?
46. Does Chemotherapy Induce Metastases?
47. Considerations About the Use of Biomarkers in Cancer Clinical Trials.
48. On Losing Paddy Johnston.
49. Regarding "Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies".
50. Advantages of a Truly Open-Access Data-Sharing Model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.